Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)


This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

Observations placeholder

Deaths from yellow fever vaccine



Type of Spiritual Experience



This paper appears to show that more people die from the vaccine than they do from yellow fever.

A description of the experience

Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6. Review of the risks and benefits of yellow fever vaccination including some new analyses. Monath TP. Kleiner Perkins Caufield & Byers, Menlo Park, CA, USA. tmonath@kpcb.com

The live, attenuated yellow fever (YF) 17D vaccine provides highly effective and durable immunity and is widely used for travelers to and residents of endemic areas of South America and Africa.

Neurotropic and viscerotropic serious adverse events associated with these vaccines occur rarely, but YF 17D vaccine-associated viscerotropic disease (YEL-AVD) is notable for its lethality.

There appear to be two distinct patterns of risk for YEL-AVD:

  • the first in younger persons, particularly women, with defects in innate immunity, in whom the case-fatality rate is higher;
  • and the second in elderly persons, particularly men with age-related immune senescence and a lower case-fatality rate.

From 1990 to the present, the number of cases (n = 31) and deaths (n = 12) from YEL-AVD in travelers has exceeded the reports of YF (n = 6) acquired by natural infection, raising the question whether the risk of vaccination exceeds the benefit in travelers.

To provide some guidance on this point, the rate of vaccine-related injury is compared with the rate of naturally acquired disease in a new analysis that estimates the immunologically susceptible denominator population in YF endemic and epidemic areas.

For many years, the risk of vaccine-related illness and death was similar to the risk of illness and death from natural infection with YF in South America.

Africa posed a substantially higher estimated risk of wild-type YF than vaccine-related injury.

Multiple factors should be considered in making decisions about YF vaccination, including specific destination, season of the year, local evidence for YF transmission, likelihood of exposure to vector mosquitoes and individual risk factors for YEL-AVD, with the goal of increasing vaccine coverage for travel to high-risk areas and reducing unnecessary vaccination. Prospects for future, safer vaccines are also described.

PMID: 22551029

The source of the experience


Concepts, symbols and science items



Science Items

Activities and commonsteps



Viral infection
Yellow fever